This issue discusses transitioning pediatric patients to the adult system, features an interview between ASH and ABIM about MOC, and provides coverage from the ASH Workshop on Genome Editing.
This issue examines the use of companion diagnostics, features patient education on acute myeloid leukemia, and provides coverage from the 2016 ASH Meeting on Lymphoma Biology.
This issue looks at online ratings for doctors, features coverage from the 2016 ASCO Annual Meeting, and debates the use of FLT3 inhibitors in older patients with AML.
This issue features an inside look at the National Cancer Moonshot Initiative and updates from the American Association for Cancer Research Annual Meeting.
This issue features highlights from the 2016 ASH Annual Meeting, a look at the dangers of predatory publishing, and more.
This issue features a look at how living with severe hemophilia changed in the last 50 years, weighing the risks and rewards of standardizing care, and a How I Teach piece on the coagulation cascade.
This issue features a conversation with hematologist/oncologists who have also been diagnosed with blood disorders themselves, as well as a look at how access to generic medications is becoming more difficult.
This supplement features updated information on late-breaking drug approvals for bleeding disorders, leukemia, and myeloma.
This issue features a look at young blood versus old blood when it comes to red blood cell transfusions, as well as additional coverage from the 2015 ASH Annual Meeting and a physician debate on optimal timing of transplant in myeloma.
This special edition takes a deep dive into coverage from the 2015 ASH Annual Meeting, including interviews with speakers and up-to-date clinical findings presented at the meeting.